Prenetics Global Ltd
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more
Prenetics Global Ltd (PRE) - Total Assets
Latest total assets as of September 2025: $196.51 Million USD
Based on the latest financial reports, Prenetics Global Ltd (PRE) holds total assets worth $196.51 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Prenetics Global Ltd - Total Assets Trend (2000–2024)
This chart illustrates how Prenetics Global Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Prenetics Global Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Prenetics Global Ltd's total assets of $196.51 Million consist of 40.3% current assets and 59.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 24.5% |
| Accounts Receivable | $5.61 Million | 2.6% |
| Inventory | $6.57 Million | 3.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $11.57 Million | 5.4% |
| Goodwill | $37.36 Million | 17.5% |
Asset Composition Trend (2000–2024)
This chart illustrates how Prenetics Global Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Prenetics Global Ltd's current assets represent 40.3% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 24.5% of total assets in 2024, up from 7.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 14.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 17.5% of total assets.
Prenetics Global Ltd Competitors by Total Assets
Key competitors of Prenetics Global Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Prenetics Global Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Prenetics Global Ltd generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Prenetics Global Ltd is currently not profitable relative to its asset base.
Prenetics Global Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.51 | 1.40 | 0.93 |
| Quick Ratio | 1.30 | 1.22 | 0.84 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $13.00 Million | $ 19.80 Million | $ -3.11 Million |
Prenetics Global Ltd - Advanced Valuation Insights
This section examines the relationship between Prenetics Global Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.28 |
| Latest Market Cap to Assets Ratio | 1.04 |
| Asset Growth Rate (YoY) | -16.0% |
| Total Assets | $213.57 Million |
| Market Capitalization | $222.02 Million USD |
Valuation Analysis
Above Book Valuation: The market values Prenetics Global Ltd's assets above their book value (1.04 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Prenetics Global Ltd's assets decreased by 16.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Prenetics Global Ltd (2000–2024)
The table below shows the annual total assets of Prenetics Global Ltd from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $213.57 Million | -15.97% |
| 2023-12-31 | $254.17 Million | -18.57% |
| 2022-12-31 | $312.13 Million | +110.18% |
| 2021-12-31 | $148.51 Million | +88.26% |
| 2020-12-31 | $78.88 Million | +165.72% |
| 2019-12-31 | $29.69 Million | -99.86% |
| 2015-12-31 | $21.41 Billion | -3.88% |
| 2014-12-31 | $22.27 Billion | -3.33% |
| 2013-12-31 | $23.04 Billion | +0.25% |
| 2012-12-31 | $22.98 Billion | +0.55% |
| 2011-12-31 | $22.86 Billion | -2.18% |
| 2010-12-31 | $23.36 Billion | -1.55% |
| 2009-12-31 | $23.73 Billion | +45.78% |
| 2008-12-31 | $16.28 Billion | +1.51% |
| 2007-12-31 | $16.04 Billion | +7.28% |
| 2006-12-31 | $14.95 Billion | +8.76% |
| 2005-12-31 | $13.74 Billion | +9.85% |
| 2004-12-31 | $12.51 Billion | +14.75% |
| 2003-12-31 | $10.90 Billion | +24.78% |
| 2002-12-31 | $8.74 Billion | +21.95% |
| 2001-12-31 | $7.17 Billion | +17.63% |
| 2000-12-31 | $6.09 Billion | -- |